PT-141 is a melanocortin agonist approved for certain forms of low sexual desire. It is researched most often for Libido & sexual arousal and Sexual dysfunction studies. FDA-approved for a specific indication. This guide walks through what PT-141 is, how it's studied, what it's commonly combined with, and — just as important — where the science stops. It's educational information only, not medical advice.
What is PT-141?
PT-141 (bremelanotide) is a melanocortin receptor agonist. Unlike vascular treatments, it acts on pathways in the nervous system related to sexual arousal, and is FDA-approved for hypoactive sexual desire disorder in some populations.
Also known as: Bremelanotide.
How does PT-141 work?
PT-141 (bremelanotide) is a melanocortin receptor agonist. Rather than acting on blood flow like vascular treatments, it works on nervous-system pathways involved in sexual arousal, and is FDA-approved for hypoactive sexual desire disorder in certain populations.
What is PT-141 researched for?
In the research and community discussion, PT-141 comes up most often in connection with Libido & sexual arousal and Sexual dysfunction studies. Remember that "researched for" is not the same as "proven to treat" — these are the directions the science has explored, not established outcomes.
- Libido & sexual arousal
- Sexual dysfunction studies
What does the research actually show?
FDA-approved for a specific indication. The honest framing matters here: promising mechanisms and early results are genuinely interesting, but they are not the same as proven, approved therapy. Anyone presenting PT-141 as a guaranteed treatment is getting ahead of the evidence.
Safety and considerations
Prescription medication. Can affect blood pressure; medical supervision advised. Because the responsible framing is educational rather than prescriptive, Selpho provides no dosing, protocols, or purchase links, and always points back to a licensed professional for any decision. If you are dealing with a real health concern, that professional — not a peptide — is where planning should start.
Where to learn more about PT-141
To go deeper, see the PT-141 library page for a quick reference; published research on PubMed; Selpho's free AI Peptide Advisor to see where PT-141 might fit your goals.
Frequently asked questions
It is FDA-approved (as bremelanotide) for premenopausal women with hypoactive sexual desire disorder. Other uses are off-label.
It acts centrally on arousal pathways via melanocortin receptors rather than on blood flow, so its mechanism differs from PDE5 inhibitors.
It can affect blood pressure and cause nausea or flushing in studies. It is a prescription medication requiring medical supervision.
Not sure if PT-141 fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis guide is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.